Here are six insights:
1. Dr. Rabchevsky is researching avenues to promote tissue sparing to enhance functional recovery. He is also looking for ways to prevent aberrant neuronal regeneration that results in hypertension.
2. Both complications following spinal cord injuries involve the dysfunction of mitochondria.
3. Dr. Rabchevsky and his team are testing pharmacological agents as mitochondria stabilizers, which could increase neuroprotection.
4. After SCI, regeneration often occurs, but establishes improper connections. This may result in autonomic dysreflexia, which involves a stimulus below the SCI causing sustained hypertension.
5. Dr. Rabchevsky has a grant to test healthy mitochondria in animals with SCI.
6. He earned his doctorate degree in neuroscience from Gainesville-based University of Florida.
More articles on spine:
Tackling variation in spine: Why are there so many ways to treat the same patient?
6 ways data impacted standard of spine care
5 key notes on new spine surgery reimbursement models
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
